Skip to content
type1.science

MicroTech Equil patch pump

MicroTech Medical

What it is

An established wearable patch pump with bolus calculation, temporary basal and extended boluses. MicroTech’s developing closed-loop program is separate; no approved AID functionality is inferred for this pump.

Editorial review: .

Source dates appear in the references where available; this record has no dated citation metadata.

Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence

Full sources ↓Full discussion ↓Report an issue →

Available nowEarly evidenceOfficial site ↗

Evidence behind this assessment

Key evidence notes. Study results, product eligibility and access answer different questions.

Who was studied?
Study populations and analysis groups vary. Product age limits alone do not describe who was studied.
Benefit or performance
Reliability: No comparative failure-rate dataset verified.[1]
Important harms and treatment burden
Read the safety discussion and original sources. A missing summary does not establish safety.
Approval and country access
Country-specific approval and access are not summarized in this record.Approval, trial recruitment, local supply and funding are separate. Check the cited label or access source.
Follow-up and remaining uncertainty
Read the full discussion and original sources for follow-up duration and study limitations.

This record cites company or conference reports. Those sources may describe interim findings; their source type is shown in the source list.

Editorial score: calculation and evidence

A weighted editorial judgment on a 0–100 scale, not a probability of success or a measured treatment effect. Higher criterion scores mean more favorable assessments.

Default calculation: 15 × 20 + 40 × 20 + 80 × 20 + 20 × 15 + 40 × 10 + 35 × 15 = 3925; divide by total weight 100. Unrounded weighted result: 39.25.

Interoperability15

No currently launched commercial AID pairing established.[3]

Reliability40

No comparative failure-rate dataset verified.[1]

Form factor80

23 g wearable patch design per manufacturer.[1]

Phone control20

Smartphone insulin control not established by the checked specifications.[1]

Capacity40

Exact current reservoir variant not independently verified; conservative editorial assessment.[1]

Access & cost35

Historical commercial markets plus current manufacturer support; local supply unconfirmed.[2]

Editor’s take

Scores are editorial judgments about the evidence and practical features, not measured comparative performance or a probability of success.

The full picture

MicroTech lists a 23 g wearable pump with a bolus calculator, temporary basal rates and extended bolus support. Its product page specifies adjustable bolus increments down to 0.025 units; local instructions determine the available settings.1

Commercialization is documented in the company’s annual report. Current June 2026 communications still distinguish Equil from a developing artificial-pancreas system, so Equil must not be described as an already commercial closed-loop product.23

Country-specific stock, funding, compatible insulins and reservoir capacity were not independently confirmed here. The score reflects documented features and uncertainty, not a measured reliability comparison.

Sources

  1. [1]
  2. [2]
    MicroTech 2023 annual report: Equil and AiDEX marketed internationally · Manufacturer

    MicroTech2023 annual report: Equil and AiDEX marketed internationally.

  3. [3]
    MicroTech June 2026 commercial products and developing closed-loop system · Manufacturer

    MicroTech June2026 commercial products and developing closed-loop system.